The Amnion Foundation is a 501(c)3 organization founded by Dr. Anthony Atala, a world-renowned leader in regenerative medicine. Today, we specialize in the provision of birth tissue-related goods and services to the scientific community. Anchoring our portfolio are proprietary stem cells isolated from the amniotic fluid or placenta; these cells are genetically stable, have a remarkable capacity for expansion, and possess a broad spectrum of therapeutically relevant functions, including immunomodulatory properties, pro-angiogenic and pro-vasculogenic properties, and multi-lineage differentiation potential. We also offer a variety of additional birth tissue-derived cell types and provide custom isolation services for our partners and clients.
The Amnion Foundation is powering our mission with a dedicated staff and a wide network of Key Opinion Leaders and Scientific Advisors, including our Founder Dr. Anthony Atala.
Sharon C. Presnell, Ph.D.
Sharon Presnell joined the Amnion Foundation as President and Director of Client Services in January of 2019. Previously, she served as the Chief Scientific Officer of Organovo, Inc., and President of Samsara Sciences, both located in San Diego, CA. Dr. Presnell holds a Ph.D. from the Medical College of Virginia, and has held academic and industrial leadership roles at UNC-Chapel Hill, Becton Dickinson, and Tengion, Inc. She brings 20+ years of experience in cell biology, scientific and business leadership to the Foundation
Julie G. Allickson, Ph.D.
chief scientific officer
Prior to joining the foundation, Dr. Allickson was an Executive Officer of the company and Vice President of Laboratory Operations and R & D at Cryo-Cell International, Inc., an AABB accredited, and Florida- based Family Cord Blood Bank. She was part of the team to perform the very first Bone Marrow Transplant at the University of Miami in 1990. She has 23 years of experience in Cellular Therapy, Cellular Processing and Regenerative Medicine. She has a Doctorate in Health Sciences along with a Master's Degree in Medical Laboratory Sciences. She is one of the founding members of the International Society of Cellular Therapy in 1992 and has been a member of the American Association of Blood Banks (AABB) for 20 years.